Company number: 04620455 Registered Charity: 1099537
European Society for Clinical Virology (Limited by guarantee) Report and Financial Statements for the year ended 31 October 2023
23/07/2024 Page 1 of 10
European Society for Clinical Virology (Limited by Guarantee)
Members of Executive - Company Directors (November 1[st] 2022 - October 31[st] 2023)
Prof. Dr. Pamela Vallely (President) Prof Dr. Mariet C.W. Feltkamp (Past President) Prof. Dr. Marcus Panning (Vice President) Prof. Dr. Maria São José Alexandre Nascimento (Vice President) Prof. Dr. Catherine Moore (General Secretary) Prof. Dr. Xavier López-Labrador (Communication Officer) Prof. Dr. George Sourvinos (Treasurer) Prof. Dr. Heli Harvala (Meetings Secretary)
Company Secretary
Ester Zoroa, Kenes Group, KAM
Page 2 of 10
European Society for Clinical Virology (Limited by Guarantee)
European Society for Clinical Virology (ESCV) details
Registered Office Charles Darwin House 12 Roger Street London Company limited by guarantee N° 04620455 Registered as a Charity in England N° 1099537 Inland Revenue reference: 610 94961 19846 A 01
Page 3 of 10
European Society for Clinical Virology (Limited by Guarantee)
Directors’ Report
The European Society for Clinical Virology (ESCV) is a Company Limited by Guarantee, first incorporated in 2003. In accordance with the Society’s Memorandum of Association, each Company Member undertakes to contribute such amount as may be required, not exceeding £1, to the Company’s assets if it should be wound up while he or she is a Company Member or within one year after he or she ceases to be so.
The Society is registered as a Charity, the Company Directors being the Charity’s Trustees.
The Company Directors acting collectively are the Society’s Executive.
The Executive hereby submits its report and financial statements for the year ending October 31[st] 2023.
Organization and Objectives
According to the articles, the Society is administered by the Executive, made up of minimum three and maximum ten Company Directors/Charity Trustees. Currently the Executive numbers eight Directors.
The ESCV has appointed a professional secretariat to handle administrative matters. This secretariat is Kenes Group, Rue François-Versonnex 7, 1207 Geneva, Switzerland.
In accordance with Article 4 the Executive admits as ‘ESCV Members’ such persons and subjects them to such rights and obligations as it thinks fit. Such ‘ESCV Members’ are not Company Members for the purposes of the Articles and are not entitled to vote on any matter save where expressly provided in the Articles.
ESCV members of different European and other countries are represented by councilors, elected by each country’s members according to procedures described in the Articles. The councilors acting collectively are the Council. The Council elects the Company Directors/Charity Trustees according to procedures described in the Articles. The Society’s objectives are to promote public health and to advance public education, in particular medical education, by:
-
improving the knowledge of viruses, particularly as it relates to the diagnosis and management of viral diseases, their pathogenesis, natural history and prevention.
-
improving diagnostic methods.
-
promoting high standards in laboratory viral diagnosis through quality assessment activities and education; and
-
promoting or developing for the benefit of the public the preparation and exchange of reference reagents.
Reserves Policy
The Executive has the policy to maintain sufficient funds to allow the Society to meet its objectives and obligations on a long-term basis, and to provide a measure of investment income. It is the objective of the Society to utilize fully each year’s net income for its charitable activities.
Page 4 of 10
European Society for Clinical Virology (Limited by Guarantee)
Review of Activities in 2022/2023
Scientific Meetings
-
Europic Meeting (virtual), June 2022.
-
ECCI Meeting, Athens, October 2022.
-
24[th] Annual Conference of the ESCV, 7-10 September 2022. Manchester (UK).
-
NGS workshop, 17-18 November 2022. Antalya (Turkey).
-
NGS workshop, 23[rd] and 24[th] January 2023. London (UK).
-
ESCV – ECCI workshop on Congenital CMV Infection, 26[th] and 27[th] April 2023. Crete (Greece).
-
25[th] Annual Conference of the ESCV, 30[th] August – 2[nd] of September 2023 Milan (Italy).
Awards given at the 25[th ] Annual Conference of the European Society for Clinical Virology 2023 (Milan)
-
Abbott Award 2023 to Dr. Marianne Graninger.
-
BioMerieux Award 2023 to Prof. Marcus Panning.
-
Gardner Lectureship Award 2023 to Dr. Charles Chiu.
-
Heine-Medin Award 2023 to Dr. Maria F Perdomo.
Travel grants and fellowships given
- 35 virologists received a grant to attend the 25[th] Annual Conference of the European Society for Clinical Virology
Training grants
- None
Business Meetings held
-
ESCV Executive Meetings were held on 2[nd] of February, 23[rd] of March, 4[th] of May, 25[th] of May, 22[nd] of June, 13[th] of July, 30[th] of August, 28[th] of September, 26[th] October and 23[rd] of November 2023.
-
Council Meeting was held on 30[th] of August 2023.
-
General Assembly was held on 1[st] of September 2023.
Page 5 of 10
European Society for Clinical Virology (Limited by Guarantee)
Future Scientific Meetings planned
- 26[th] Annual Conference of the ESCV, 17[th] – 21[st] September 2024 (Frankfurt, Germany).
Signed on behalf of the Executive (Company Directors),
Prof. Dr. Pam Vallely Company President
Page 6 of 10
European Society for Clinical Virology (Limited by Guarantee)
Statement of financial activities (incorporating the income and expenditure account) Year ended 31 0ctober 2023
Page 7 of 10
European Society lor Clinical Virology (Limited by Guarantee) IDcottte & Lippnye5 frottt l Novernber 2022 10 31 Octuber 2011 2023 El-,R 21123 I-BP 0_¥7737 2022 EliR 2022 C.BP 0.85741 Notes Ii%c.'()Mks Mc]nbct5tLLP fe¢5 SwTh5015Iup CongTC55 irico 30.583 5.6111 47,7111 26.679 4'WII 41'62X 10.303 26'1NKI 77,61? 17.418 2?'305 66.5x3 83'9Jg 73,208 123.91. 106.31 EXPEYSE. Trnvcl grants Workslvjp ¢XFth5 ConBTC55 Cx1]IsC5 Jour[1 cxrw5 Adminisiraiivc cxpensc5 Bank ¢har8ts $4'5711 91.469 23.378 4,6 17.640 6.604 73,783 79.795 20,394 4'1Y)I 15.389 5.761 40.242 34.523 2.371 22.272 1.748 2.034 19.107 1'5(Kl 228.349 199.213 66.633 Net wt5uIt ofthe vear -144.441 49.142 Page80110
European Society for Clinical Virology (Limited by Guarantee)
Audit Exemption
(a) For the year ended 31 October 2023 the company was entitled to exemption from audit under section 477(2) of the Companies Act 2006 relating to small companies.
(b) Members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
- (c) The directors acknowledge their responsibility for:
i. ensuring the company keeps accounting records which comply with section 386; and
ii. preparing accounts which give a true and fair view of the state of affairs of the company as at the end of the financial year, and of its profit or loss for the financial year, in accordance with the requirements of section 393, and which otherwise comply with the requirements of the Companies Act relating to accounts, so far as applicable to the company.
(d) These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime.
Approved by Executive on 3[rd] June 2024 and signed on its behalf by Prof. Dr. Pam Vallely (Company President).
Prof. Pamela Vallely Company President
Page 9 of 10
European Society for Clinical Virology (Limited by Guarantee)
This page is left blank intentionally (last page)
Page 10 of 10
European Society for Clinical Virology
(Company limited by guarantee)
London - United Kingdom
Financial Statements
as at
31 October 2023
EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON
Balance sheet accounts as at October 31, 2023
| 2023 | 2023 | 2022 | 2022 | ||
|---|---|---|---|---|---|
| Notes | EUR | GBP | EUR | GBP | |
| 0.87237 | 0.85790 | ||||
| ASSETS | |||||
| Bank account | 3 | 197’958 | 172’692 | 318’476 | 273’220 |
| 197’958 | 172’692 | 318’476 | 273’220 | ||
| LIABILITIES | |||||
| Accounts payable | 23’922 | 20’869 | - | - | |
| 23’922 | 20’869 | - | - | ||
| GENERAL RESERVES | |||||
| General reserves brought forward | 318’476 | 273’220 | 261’194 | 224’078 | |
| Result of the year | -144’440 | -126’005 | 57’282 | 49’142 | |
| Foreign exchange conversion | - | 4’608 | - | - | |
| 174’036 | 151’823 | 318’476 | 273’220 | ||
| 197’958 | 172’692 | 318’476 | 273’220 |
Authorized signature
Authorized signature
Date _______
The notes to the accounts form part of these financial statements Page 2
EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON Income & Expenses from 1 November 2022 to 31 October 2023
| Notes INCOMES Membership fees Sponsorship Congress income EXPENSES Travel grants Workshop expenses Congress expenses Journal expenses Administrative expenses Bank charges Net result of the year |
2023 2023 EUR GBP 0.87237 30’583 26’679 5’618 4’901 47’718 41’628 83’919 73’208 84’578 73’783 91’469 79’795 23’378 20’394 4’690 4’091 17’640 15’389 6’604 5’761 228’359 199’213 -144’440 -126’005 |
2022 2022 EUR GBP 0.85790 20’303 17’418 26’000 22’305 77’612 66’583 |
|---|---|---|
| 123’915 106’306 |
||
| 40’242 34’523 - - - - 2’371 2’034 22’272 19’107 1’748 1’500 |
||
| 66’633 57’164 |
||
| 57’282 49’142 |
The notes to the accounts form part of these financial statements Page 3
EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON Notes to the Accounts of October 31, 2023
1- GENERAL
EUROPEAN SOCIETY FOR CLINICAL VIROLOGY "ESCV”, is registered as Charity under reference number 1099537.
The Private Limited Company by guarantee reference number is 04620455.
ESCV was incorporated on December 18, 2002.
The mission of ESCV is to provide a forum for virologists, scientists and physicians interested in all aspects of Clinical Virology and human viral diseases.
The registered office is at Charles Darwin House, 12 Roger Street, London WC1N 2JU, United Kingdom.
ESCV officers are :
-
Pamela Josephine Vallely
-
Catherine Moore
-
Xavier Lopez Labrador
-
Georgios Sourvinos
-
Mariet Feltkamp
-
Heli Harvala
-
Maria Sao Jose Garcia Alexandre Naschimento
-
Marcus Panning
2 - AUDIT EXEMPTION
For the year ended 31 October 2023, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibility for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime.
3 – EMPLOYEES
No employees for this year.
4 – BANK ACCOUNT
Represent unrestricted cash balance in Euro held at BBVA Bank in Spain.
Page 4
E CHARITY COMMISSION FOR ENGLAND AND WALES
‘ Independent examiner's report on the accounts
Section A Independent Examiner’s Report
-
Report to the trustees/ | Che"yNeme nF members of | European Society for Clinical Virology
-
On accounts for the year | 31°t October 2023 Charity no | 1099537 ended (if any) | report to the trustees on my examination of the accounts of the above charity (“the Trust”) for the year ended 31/10/2023.
-
Responsibilities and As the charity trustees of the Trust, you are responsible for the preparation basis of report of the accounts in accordance with the requirements of the Charities Act 2011 (“the Act”).
- | report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination, | have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
-
Independent | have completed my examination. | confirm that no material matters have examiner's statement come to my attention (other than that disclosed below *) in connection with the examination which gives me cause to believe that in, any material respect:
- e accounting records were not kept in accordance with section 130 of the Act or - e the accounts do not accord with the accounting records
| have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached. * Please delete the words in the brackets if they do not apply.
Signed: | Ayo Imo
----- Start of picture text -----
Date: | July 1 2024
----- End of picture text -----
Name: | Annelies Riezebos-Brilman
Relevant professional | Consultant medical microbiology qualification(s) or body
(if any):
Address: | Laboratory for Medical Microbiology and Public Health
P.O. box 516 7550 AM Hengelo (ov.)
The Netherlands
IER
1
October 2018
Section B
Disclosure
Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts: directions and guidance for examiners).
Give here brief details of any items that the examiner wishes to disclose.
IER
2
October 2018